In the US, Kefzol (cefazolin systemic) is a member of the drug class first generation cephalosporins and is used to treat Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Cholecystitis, Endocarditis, Joint Infection, Kidney Infections, Peritonitis, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Septicemia, Skin or Soft Tissue Infection, Surgical Prophylaxis and Urinary Tract Infection.
Ingredient matches for Kefzol
Cefazolin is reported as an ingredient of Kefzol in the following countries:
Cefazolin sodium (a derivative of Cefazolin) is reported as an ingredient of Kefzol in the following countries:
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Kefzol in the following countries:
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.